{"id":722,"date":"2026-09-01T15:21:54","date_gmt":"2026-09-01T15:21:54","guid":{"rendered":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/"},"modified":"2026-09-01T15:32:23","modified_gmt":"2026-09-01T15:32:23","slug":"retatrutide-phase-2-obesity-trial-338-adults-48-weeks","status":"publish","type":"case_study","link":"https:\/\/nhdbio.com\/ja\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/","title":{"rendered":"Retatrutide \u30d5\u30a7\u30fc\u30ba 2 \u80a5\u6e80\u8a66\u9a13: 48 \u9031\u9593\u306b\u308f\u305f\u308b\u6210\u4eba 338"},"content":{"rendered":"<h2>\u3053\u306e\u7814\u7a76\u304c\u983b\u7e41\u306b\u5f15\u7528\u3055\u308c\u308b\u7406\u7531<\/h2>\n<p>Retatrutide \u306f\u3001GIP\u3001GLP-1\u3001\u304a\u3088\u3073\u30b0\u30eb\u30ab\u30b4\u30f3\u53d7\u5bb9\u4f53\u3092\u6d3b\u6027\u5316\u3059\u308b\u3088\u3046\u306b\u8a2d\u8a08\u3055\u308c\u307e\u3057\u305f\u3002 2023 \u8ad6\u6587\u306f\u3001\u80a5\u6e80\u306b\u304a\u3051\u308b\u3053\u306e\u5316\u5408\u7269\u306e\u30d2\u30c8\u7528\u91cf\u7bc4\u56f2\u306e\u4e2d\u5fc3\u7684\u306a\u30d4\u30a2\u30ec\u30d3\u30e5\u30fc\u6e08\u307f\u8a18\u9332\u3067\u3042\u308b\u305f\u3081\u3001\u7528\u91cf\u30b0\u30eb\u30fc\u30d7\u3001\u30d7\u30e9\u30bb\u30dc\u306e\u7d50\u679c\u3001\u307e\u305f\u306f\u5b89\u5168\u6027\u89b3\u5bdf\u3092\u542b\u307e\u305a\u306b\u6700\u5927\u306e\u5909\u5316\u7387\u306e\u307f\u3092\u8a18\u8f09\u3057\u305f\u8981\u7d04\u3088\u308a\u3082\u6709\u7528\u3067\u3059\u3002<\/p>\n<h2>\u88c1\u5224\u306f\u3069\u306e\u3088\u3046\u306b\u69cb\u6210\u3055\u308c\u305f\u304b<\/h2>\n<p>BMI \u304a\u3088\u3073\u4f53\u91cd\u95a2\u9023\u306e\u72b6\u614b\u306e\u57fa\u6e96\u3092\u6e80\u305f\u3059\u6210\u4eba\u3092\u30016 \u3064\u306e\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u30ec\u30b8\u30e1\u30f3\u3068\u30d7\u30e9\u30bb\u30dc\u306b\u308f\u305f\u3063\u3066\u7121\u4f5c\u70ba\u306b\u5272\u308a\u4ed8\u3051\u307e\u3057\u305f\u3002\u914d\u5206\u6bd4\u7387\u3068\u7570\u306a\u308b\u958b\u59cb\u7528\u91cf\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u306f\u8a2d\u8a08\u306e\u4e00\u90e8\u3067\u3042\u308a\u3001\u3053\u308c\u306f\u7814\u7a76\u304c\u6709\u52b9\u6027\u30b7\u30b0\u30ca\u30eb\u3060\u3051\u3067\u306a\u304f\u7528\u91cf\u53cd\u5fdc\u3068\u5fcd\u5bb9\u6027\u3082\u8a55\u4fa1\u3057\u3066\u3044\u308b\u3053\u3068\u3092\u610f\u5473\u3057\u307e\u3059\u3002\u9031 24 \u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u306f\u30d7\u30e9\u30a4\u30de\u30ea\u3067\u3057\u305f\u3002\u9031 48 \u306f\u4e8c\u6b21\u3067\u3057\u305f\u3002<\/p>\n<h2>\u6570\u5b57\u306e\u610f\u5473<\/h2>\n<p>\u5831\u544a\u3055\u308c\u305f\u6700\u5927\u306e\u5e73\u5747\u5909\u5316\u306f12 mg\u30b0\u30eb\u30fc\u30d7\u3067\u767a\u751f\u3057\u307e\u3057\u305f\u304c\u3001\u3053\u306e\u51fa\u7248\u7269\u3067\u306f1\u30014\u30018 mg\u30b0\u30eb\u30fc\u30d7\u5168\u4f53\u306e\u6bb5\u968e\u7684\u53cd\u5fdc\u3068\u30d7\u30e9\u30bb\u30dc\u6bd4\u8f03\u3082\u5831\u544a\u3057\u3066\u3044\u307e\u3059\u3002 48 \u9031\u306e\u95be\u5024\u7d50\u679c\u3082\u540c\u69d8\u306b\u30b0\u30eb\u30fc\u30d7\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3057\u305f\u3002\u3053\u308c\u3089\u306f\u30b0\u30eb\u30fc\u30d7\u30ec\u30d9\u30eb\u306e\u8a66\u9a13\u306e\u63a8\u5b9a\u5024\u3067\u3042\u308a\u3001\u500b\u4eba\u306e\u4e88\u6e2c\u3067\u306f\u306a\u304f\u3001\u540c\u3058\u5316\u5408\u7269\u540d\u3067\u8ca9\u58f2\u3055\u308c\u3066\u3044\u308b\u88fd\u54c1\u304c\u7814\u7a76\u4ecb\u5165\u3068\u4e92\u63db\u6027\u304c\u3042\u308b\u3068\u3044\u3046\u8a3c\u62e0\u3067\u3082\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<div class=\"pfm-case-callout\"><strong>\u89e3\u91c8\u30c1\u30a7\u30c3\u30af:<\/strong> \u983b\u7e41\u306b\u7e70\u308a\u8fd4\u3055\u308c\u308b -24.2% \u306e\u6570\u5024\u306f\u300148 \u9031\u306b\u304a\u3051\u308b 1 \u3064\u306e\u30e9\u30f3\u30c0\u30e0\u5316\u30b0\u30eb\u30fc\u30d7\u306e\u6700\u5c0f\u4e8c\u4e57\u5e73\u5747\u3067\u3059\u3002\u3053\u308c\u306f\u53c2\u52a0\u8005\u5168\u54e1\u306e\u7d50\u679c\u3067\u306f\u306a\u304f\u3001\u76f4\u63a5\u306e\u30ec\u30bf\u30c8\u30eb\u30c1\u30c9\u5bfe\u30c1\u30eb\u30bc\u30d1\u30c1\u30c9\u8a66\u9a13\u306b\u3088\u3063\u3066\u5f97\u3089\u308c\u305f\u3082\u306e\u3067\u3082\u3042\u308a\u307e\u305b\u3093\u3002<\/div>\n<h2>\u672a\u89e3\u6c7a\u306e\u307e\u307e\u6b8b\u3063\u3066\u3044\u308b\u3082\u306e<\/h2>\n<p>\u3053\u306e\u8a66\u9a13\u306f\u30012 \u76f8\u306e\u30d2\u30c8\u30b7\u30b0\u30ca\u30eb\u3068\u7528\u91cf\u53cd\u5fdc\u306e\u8b70\u8ad6\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u9577\u671f\u7684\u306a\u30e1\u30f3\u30c6\u30ca\u30f3\u30b9\u3001\u307e\u308c\u306a\u6709\u5bb3\u4e8b\u8c61\u3001\u6709\u52b9\u6027\u306e\u6bd4\u8f03\u3001\u88fd\u9020\u4e0a\u306e\u540c\u7b49\u6027\u3001\u307e\u305f\u306f\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u3092\u89e3\u6c7a\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3053\u308c\u3089\u306e\u8cea\u554f\u306b\u306f\u3001\u305d\u306e\u5f8c\u306e\u8a66\u9a13\u3068\u898f\u5236\u5f53\u5c40\u304c\u30ec\u30d3\u30e5\u30fc\u3057\u305f\u88fd\u54c1\u30c7\u30fc\u30bf\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>\u7528\u91cf\u7fa4\u306e\u7d50\u679c\u3001\u6709\u5bb3\u4e8b\u8c61\u306e\u30d1\u30bf\u30fc\u30f3\u3001\u81e8\u5e8a\u4ecb\u5165\u8a18\u9332\u3092\u7814\u7a76\u6750\u6599\u306b\u9069\u7528\u3059\u308b\u9650\u754c\u306a\u3069\u3001\u7121\u4f5c\u70ba\u5316\u30d5\u30a7\u30fc\u30ba2\u80a5\u6e80\u8a66\u9a13\u306b\u95a2\u3059\u308b\u60c5\u5831\u6e90\u8ffd\u8de1\u53ef\u80fd\u306a\u8aad\u307f\u53d6\u308a\u5024\u3002<\/p>","protected":false},"author":0,"featured_media":850,"template":"","class_list":["post-722","case_study","type-case_study","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Retatrutide Phase 2 Trial: 338 Adults, 48 Weeks<\/title>\n<meta name=\"description\" content=\"A source-traceable reading of the randomized Phase 2 obesity trial, including the dose-group results, adverse-event pattern and the limits of applying a clinical intervention record to research material.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/ja\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Retatrutide Phase 2 Obesity Trial: 338 Adults Over 48 Weeks\" \/>\n<meta property=\"og:description\" content=\"A source-traceable reading of the randomized Phase 2 obesity trial, including the dose-group results, adverse-event pattern and the limits of applying a clinical intervention record to research material.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/ja\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T15:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/retatrutide-phase-2-editorial-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/\",\"name\":\"Retatrutide Phase 2 Trial: 338 Adults, 48 Weeks\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/retatrutide-phase-2-editorial-v2.webp\",\"datePublished\":\"2026-09-01T15:21:54+00:00\",\"dateModified\":\"2026-09-01T15:32:23+00:00\",\"description\":\"A source-traceable reading of the randomized Phase 2 obesity trial, including the dose-group results, adverse-event pattern and the limits of applying a clinical intervention record to research material.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/retatrutide-phase-2-editorial-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/retatrutide-phase-2-editorial-v2.webp\",\"width\":1672,\"height\":941,\"caption\":\"Editorial research illustration; not a photograph of trial participants or an actual study site.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u6848\u4f8b\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/case-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Retatrutide Phase 2 Obesity Trial: 338 Adults Over 48 Weeks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Retatrutide \u30d5\u30a7\u30fc\u30ba 2 \u8a66\u9a13: \u6210\u4eba 338\u300148 \u9031\u9593","description":"\u7528\u91cf\u7fa4\u306e\u7d50\u679c\u3001\u6709\u5bb3\u4e8b\u8c61\u306e\u30d1\u30bf\u30fc\u30f3\u3001\u81e8\u5e8a\u4ecb\u5165\u8a18\u9332\u3092\u7814\u7a76\u6750\u6599\u306b\u9069\u7528\u3059\u308b\u9650\u754c\u306a\u3069\u3001\u7121\u4f5c\u70ba\u5316\u30d5\u30a7\u30fc\u30ba2\u80a5\u6e80\u8a66\u9a13\u306b\u95a2\u3059\u308b\u60c5\u5831\u6e90\u8ffd\u8de1\u53ef\u80fd\u306a\u8aad\u307f\u53d6\u308a\u5024\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/ja\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/","og_locale":"ja_JP","og_type":"article","og_title":"Retatrutide Phase 2 Obesity Trial: 338 Adults Over 48 Weeks","og_description":"A source-traceable reading of the randomized Phase 2 obesity trial, including the dose-group results, adverse-event pattern and the limits of applying a clinical intervention record to research material.","og_url":"https:\/\/nhdbio.com\/ja\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/","og_site_name":"NHD","article_modified_time":"2026-09-01T15:32:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/retatrutide-phase-2-editorial-v2.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"1\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/","url":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/","name":"Retatrutide \u30d5\u30a7\u30fc\u30ba 2 \u8a66\u9a13: \u6210\u4eba 338\u300148 \u9031\u9593","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/retatrutide-phase-2-editorial-v2.webp","datePublished":"2026-09-01T15:21:54+00:00","dateModified":"2026-09-01T15:32:23+00:00","description":"\u7528\u91cf\u7fa4\u306e\u7d50\u679c\u3001\u6709\u5bb3\u4e8b\u8c61\u306e\u30d1\u30bf\u30fc\u30f3\u3001\u81e8\u5e8a\u4ecb\u5165\u8a18\u9332\u3092\u7814\u7a76\u6750\u6599\u306b\u9069\u7528\u3059\u308b\u9650\u754c\u306a\u3069\u3001\u7121\u4f5c\u70ba\u5316\u30d5\u30a7\u30fc\u30ba2\u80a5\u6e80\u8a66\u9a13\u306b\u95a2\u3059\u308b\u60c5\u5831\u6e90\u8ffd\u8de1\u53ef\u80fd\u306a\u8aad\u307f\u53d6\u308a\u5024\u3002","breadcrumb":{"@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/retatrutide-phase-2-editorial-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/retatrutide-phase-2-editorial-v2.webp","width":1672,"height":941,"caption":"Editorial research illustration; not a photograph of trial participants or an actual study site."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/case-studies\/retatrutide-phase-2-obesity-trial-338-adults-48-weeks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"\u6848\u4f8b","item":"https:\/\/nhdbio.com\/case-studies\/"},{"@type":"ListItem","position":3,"name":"Retatrutide Phase 2 Obesity Trial: 338 Adults Over 48 Weeks"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"\u30da\u30d7\u30c1\u30c9\u539f\u6599\u30fb\u30ab\u30b9\u30bf\u30e0\u30da\u30d7\u30c1\u30c9\u5408\u6210","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/case_study\/722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/case_study"}],"about":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/types\/case_study"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/case_study\/722\/revisions"}],"predecessor-version":[{"id":727,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/case_study\/722\/revisions\/727"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media\/850"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/ja\/wp-json\/wp\/v2\/media?parent=722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}